These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women. Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128 [TBL] [Abstract][Full Text] [Related]
3. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation. Herraiz I; López-Jiménez EA; García-Burguillo A; Nieto O; Villar OP; Escribano D; Galindo A Ultrasound Obstet Gynecol; 2009 May; 33(5):518-23. PubMed ID: 19402101 [TBL] [Abstract][Full Text] [Related]
4. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509 [TBL] [Abstract][Full Text] [Related]
5. High macrosomia rate in healthy fetuses after enlarged nuchal translucency. Timmerman E; Pajkrt E; Snijders RJ; Bilardo CM Prenat Diagn; 2014 Feb; 34(2):103-8. PubMed ID: 24155168 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal trends in fetoplacental biochemical markers, uterine artery pulsatility index and maternal blood pressure during the first trimester of pregnancy. Wortelboer EJ; Koster MP; Kuc S; Eijkemans MJ; Bilardo CM; Schielen PC; Visser GH Ultrasound Obstet Gynecol; 2011 Oct; 38(4):383-8. PubMed ID: 21520474 [TBL] [Abstract][Full Text] [Related]
7. First and second trimester screening for large for gestational age infants. González González NL; Plasencia W; González Dávila E; Padrón E; di Renzo GC; Bartha JL J Matern Fetal Neonatal Med; 2013 Nov; 26(16):1635-40. PubMed ID: 23668692 [TBL] [Abstract][Full Text] [Related]
15. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399 [TBL] [Abstract][Full Text] [Related]
16. First trimester maternal serum PAPP-A and free β-hCG levels and risk of SGA or LGA in women with and without GDM. Kantomaa T; Vääräsmäki M; Gissler M; Ryynänen M; Nevalainen J BMC Pregnancy Childbirth; 2024 Sep; 24(1):580. PubMed ID: 39242998 [TBL] [Abstract][Full Text] [Related]
17. Performance of third-trimester ultrasound for prediction of small-for-gestational-age neonates and evaluation of contingency screening policies. Souka AP; Papastefanou I; Pilalis A; Michalitsi V; Kassanos D Ultrasound Obstet Gynecol; 2012 May; 39(5):535-42. PubMed ID: 21858886 [TBL] [Abstract][Full Text] [Related]
18. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both. Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353 [TBL] [Abstract][Full Text] [Related]